USANA Health Sciences, Inc. ($USNA) - Quick Stock Analysis

TL;DR

Usana Health Sciences is a slow-growing company with a market cap of $1.7 billion, consistent profit growth, high insider ownership, and strong financials.

Transcript

this is an eight isn't this an eight pillar one it looks like this might be uh in our wheelhouse i think it's the color one i think it's one of the twenty one better yeah this is on your list paul people are saying so okay you want to look at this let's look at it this is uh this is usana health this is science girl asana health sciences what is th... Read More

Key Insights

• 🐢 Usana Health Sciences is a slow-growing company with low revenue growth over the past five years.
• ❓ The company's profit growth has been consistent but not significant.
• 🥹 The presence of 40% insider-held stocks indicates strong alignment between insiders' goals and shareholders' interests.
• 💪 Usana Health Sciences has strong financials, with more current assets than current and total liabilities.
• 🧑‍⚕️ With a market cap of $1.7 billion, Usana Health Sciences is in the health and wellness industry.
• ❓ The company's financials suggest it may be undervalued, but a more detailed analysis is necessary to account for nuances.
• ↩️ The expected return on investment for Usana Health Sciences is around 10%.

Questions & Answers

Q: What is the market cap of Usana Health Sciences?

Usana Health Sciences has a market cap of $1.7 billion.

Q: Has the company shown consistent profit growth?

Yes, the company has consistently grown its profits over the last five years, although not at a significant rate.

Q: Why is insider ownership important for investors?

Insider ownership is important because it shows that the company's insiders have a vested interest in the company's success and are more likely to work towards improving it.

Q: How do Usana Health Sciences' financials look?

The company has strong financials, with current assets of $386 million and current liabilities of $160 million, indicating a healthy financial position.

Q: What is the expected return on investment for Usana Health Sciences?

Based on the analysis, an expected return of 10% is suggested, which translates to a price range of $44 to $60 per share.

Summary & Key Takeaways

• Usana Health Sciences has a market cap of $1.7 billion, a PE ratio of 14.74, and a profit margin of 10.22%. However, its revenue growth over the past five years has been slow.

• The company's profit growth over the last five years has been consistent but not significant, showing a growth from 95 to 100.

• Usana Health Sciences has 40% insider-held stocks, indicating strong alignment between insiders and shareholders' interests.

• The company has strong financials, with current assets of $386 million, current liabilities of $160 million, and total liabilities of $188 million. Deducting the total liabilities, the market cap reduces to $1.45 billion.